JM Gaspoz, PG Coxson, PA Goldman, LW … - The New England journal of medicine, 2002 - nejm.highwire.org 1800 · N Engl J Med, Vol. 346, No. 23 · June 6, 2002 · www.nejm.org ... COST
EFFECTIVENESS OF ASPIRIN, CLOPIDOGREL, OR BOTH FOR SECONDARY PREVENTION OF
CORONARY HEART DISEASE ... J EAN -M ICHEL G ASPOZ , MD, P AMELA G. C ... Cited by 219 - Related articles - BL Direct - All 10 versions
- ►diabetesjournals.org SI McFarlane, SJ Jacober, N Winer, J Kaur, … - Diabetes Care, 2002 - Am Diabetes Assoc OBJECTIVE—There are national mandates to reduce blood pressure (BP) to <130/85
mmHg, LDL cholesterol to <100 mg/dl, and HbA 1c to <7% and to institute aspirin
therapy in patients with diabetes. The objective of this study was to ... Cited by 177 - Related articles - BL Direct - All 6 versions
- ►ahajournals.org A Filippi, AA Bignamini, E Sessa, F Samani, … - Stroke, 2003 - Am Heart Assoc Results— We selected 2555 patients with diagnosis of stroke and 2755 with TIA.
Among all of the subjects, 32.6% had no BP recorded. Among the remaining
subjects, 58.7% reported uncontrolled BP. Isolated systolic hypertension ... Cited by 57 - Related articles - BL Direct - All 8 versions
- Free from Publisher SL Krein, S Vijan, LM Pogach, MM Hogan, EA … - Diabetes Care, 2002 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—A random sample of diabetic patients receiving
care in the Department of Veterans Affairs health care system were surveyed
during January-March 2000. The association between aspirin counseling, ... Cited by 51 - Related articles - BL Direct - All 6 versions
JA Colwell - Endocrinology and metabolism clinics of North America, 2001 - Elsevier Vascular thrombosis is a hallmark of type 2 diabetes. 16 Coronary artery
thrombosis is the leading cause of death among people with type 2 diabetes. 63
Whereas the rate of cardiovascular mortality has steadily decreased in the ... Cited by 41 - Related articles - BL Direct - All 5 versions
SD Persell, DW Baker - Archives of Internal Medicine, 2004 - archinte.highwire.org You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Add to CiteULike Add to ... Cited by 39 - Related articles - All 5 versions
- ►diabetesjournals.org A Filippi, A Sabatini, L Badioli, F Samani, G … - Diabetes Care, 2003 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—A randomized controlled trial was carried out
among 300 GPs and their patients selected from the Health Search Database. Among
these, 150 GPs (intervention group) received instructions to activate an ... Cited by 37 - Related articles - BL Direct - All 6 versions
- ►diabetesjournals.org B Ryerson, EF Tierney, TJ Thompson, MM … - Diabetes Care, 2003 - Am Diabetes Assoc RESULTS—People with diabetes had a higher proportion of any physical
limitation than did people without diabetes overall (66 vs. 29%, P < 0.001), for
both men (59 vs. 24%, P < 0.001) and women (72 vs. 34%, P < 0.001). ... Cited by 35 - Related articles - BL Direct - All 5 versions
C Watala - Current pharmaceutical design, 2005 - ingentaconnect.com Abstract: Blood platelets play a crucial role in physiological haemostasis and
in pathology of prothrombotic states, including atherosclerosis. In this paper,
we review major factors underlying altered platelet reactivity, with ... Cited by 32 - Related articles - All 5 versions
